Research News and Research

RSS

Statement updating details on testing of IDenta-Alert explosive detectors released

International drug & explosives detection firm IDenta Corp. (PINKSHEETS: IDTA) releases statement updating details about US Department of Defense testing of the IDenta-Alert explosive detectors.

1 Sep 2009

LTS LOHMANN Therapie-Systeme celebrates 25th anniversary

LTS LOHMANN Therapie-Systeme AG, the leading developer and manufacturer of transdermal, topical and oral systems with facilities in Andernach, Germany and West Caldwell, New Jersey, celebrates its 25th anniversary.

1 Sep 2009

St. Baldrick’s Foundation to organize fund raiser for childhood cancer research

Dozens of men, women and children are expected to shave their heads bald to show solidarity to children with cancer and to raise money for childhood cancer research September 19, 2009 at 5:00 at The Friendly Sons of the Shillelagh Club in West Orange, NJ.

1 Sep 2009

NASDAQ Stock Market issues noncompliance letter to Encorium Group

Encorium Group, Inc. (Nasdaq: ENCO), a full service multinational clinical research organization (CRO) conducting studies in over 30 countries for many of the world's leading pharmaceutical and biotechnology companies, today announced that on August 25, 2009, it received a letter from The NASDAQ Stock Market notifying the Company that, based on its Form 10-Q for the period ended June 30, 2009, NASDAQ has determined that the Company's stockholders' equity does not comply with the minimum $2.5 million stockholders' equity requirement for continued listing on The NASDAQ Capital Market as required by NASDAQ Marketplace Rule 5550(b)(1).

1 Sep 2009

CompAnalyst helps healthcare providers gain insight into competitive salary data

Salary.com, Inc., a leading provider of on-demand compensation, payroll and talent management solutions, is providing several healthcare providers with on-demand market pricing software to help them gain insight into competitive salary data.

1 Sep 2009

Bio-Rad cycle riders raise $73,055 during the Napa Valley Tour de Cure to benefit the ADA

Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a multinational manufacturer and distributor of life science research and clinical diagnostics products, helped raise approximately $1.1 million during the Napa Valley Tour de Cure, which took place on May 3 to benefit the American Diabetes Association.

1 Sep 2009

Cannasat Therapeutics announces completion of second tranche of prospectus offering

Cannasat Therapeutics Inc. ("Cannasat") (TSX VENTURE:CTH) is pleased to announce that it has completed a second tranche of its previously announced short form prospectus offering of units. Pursuant to the second tranche, Cannasat issued and sold 1,789,000 units at a price of $0.10 per unit raising gross proceeds of $178,900. This brings the total number of units sold under the prospectus offering to 9,298,500 for gross proceeds of $929,850.

1 Sep 2009

Poll finds more confidence about paying for health care; young adults most supportive of reform

A new survey finds growing confidence in Americans' ability to pay for health care costs. Meanwhile, young adults are the group most supportive of health reform.

1 Sep 2009

Research reveals that large non-coding RNA in mammals play an important role in telomere maintenance

A team of researchers from The Wistar Institute have shown that a large non-coding RNA in mammals and yeast plays a central role in helping maintain telomeres, the tips of chromosomes that contain important genetic information and help regulate cell division. Since this RNA also facilitates the formation of DNA at telomeres-a process that can protect aging cells and destabilize tumor cells-manipulating its expression may be useful in treating cancer and other diseases.

1 Sep 2009

New gene therapy vector developed for transferring therapeutic DNA to a cell's nucleus

A research report featured on the cover of the September 2009 print issue of The FASEB Journal describes how Australian scientists developed a new gene therapy vector that uses the same machinery that viruses use to transport their cargo into our cells. As a result of this achievement, therapeutic DNA can be transferred to a cell's nucleus far more efficiently than in the past, raising hopes for more effective treatment of genetic disorders and some types of cancers.

1 Sep 2009

Rodents may serve as useful models to interpret parent-offspring relationships

Researchers at the Yerkes National Primate Research Center, Emory University, have demonstrated that prairie voles may be a useful model in understanding the neurochemistry of social behavior. By influencing early social experience in prairie voles, researchers hope to gain greater insight into what aspects of early social experience drive diversity in adult social behavior.

1 Sep 2009

GenoCAD project receives financial support from NSF

The National Science Foundation (NSF) has awarded a three-year $1,421,725 grant to Jean Peccoud, associate professor at the Virginia Bioinformatics Institute at Virginia Tech, to develop GenoCAD - a web-based Computer Assisted Design environment for synthetic biology.

1 Sep 2009

Chemists design polymer-coated nanorods for drug manufacturers

Nanoparticles combining platinum and gold act as superefficient catalysts, but chemists have struggled to create them in an industrially useful form. Rice University chemists have answered the call this week with a polymer-coated version of gold-platinum nanorods, the first catalysts of their kind that can be used in the organic solvents favored by chemical and drug manufacturers.

1 Sep 2009

House bill would strengthen federal comparative effectiveness programs

The Christian Science Monitor: "Should the US government mount a comprehensive effort to evaluate the strengths and weaknesses of various treatments for health conditions? That question is at the heart of a dispute over whether some provisions in the healthcare reform bills now under consideration in Congress eventually might lead to the rationing of care. At issue is comparative effectiveness research, which tries to figure out just how well drugs, medical devices, and surgical techniques work, compared with alternatives. Both the House and current Senate versions of health legislation would expand exisitng federal efforts in this area."

1 Sep 2009

Tel Aviv University researcher devises mathematical formula for protecting the genetic privacy

Last year, after a published paper found serious security holes in the way DNA data is made publicly available, health institutes in the United States and across the world removed all genetic data from public access.

1 Sep 2009

ChromoCure releases development plan for CS300 Chromosomal Scanner

ChromoCure, Inc. (PINKSHEETS: KKUR) released today its development plan for its next generation of chromosomal scanners. The new system has been given the name "CS300" as the next iteration of its current CS200 Chromosomal Scanner design.

1 Sep 2009

Globe and Mail examines HIV/AIDS rate in India

The Globe and Mail writes that "[w]hen India announced in 2007 that it had 2.3 million people living with HIV, rather than the 5.7 million reported the year before, the government first attributed much of the change to better data collection. Many in the AIDS field were skeptical."

1 Sep 2009

HearAtLast's Hearing Store Clinics offer "The QSound EarBud" across Canada

HearAtLast Holdings, Inc. (PINKSHEETS: HRAL), a leading provider of suitable affordable solutions to clients with hearing needs in the billion dollar hearing loss market, announced today the exclusive offering of the "The QSound EarBud" throughout its Hearing Store Clinics located across Canada.

1 Sep 2009

New technique developed for the treatment of cancer

A new paradigm in the way we look at cancer with important implications on how we treat it is about to be published in the British Journal of Cancer by Portuguese, Belgian and American researchers.

1 Sep 2009

Managing costs for clinical trials is a big challenge

In the drug industry, clinical trials carry price tags that run well into the tens of millions of dollars. Managing such costs demands a sure hand, and trial sponsors go to great lengths to monitor and manage funds allocated to vendors.

1 Sep 2009

Research News and Research

Statement updating details on testing of IDenta-Alert explosive detectors released

LTS LOHMANN Therapie-Systeme celebrates 25th anniversary

St. Baldrick’s Foundation to organize fund raiser for childhood cancer research

NASDAQ Stock Market issues noncompliance letter to Encorium Group

CompAnalyst helps healthcare providers gain insight into competitive salary data

Bio-Rad cycle riders raise $73,055 during the Napa Valley Tour de Cure to benefit the ADA

Cannasat Therapeutics announces completion of second tranche of prospectus offering

Poll finds more confidence about paying for health care; young adults most supportive of reform

Research reveals that large non-coding RNA in mammals play an important role in telomere maintenance

New gene therapy vector developed for transferring therapeutic DNA to a cell's nucleus

Rodents may serve as useful models to interpret parent-offspring relationships

GenoCAD project receives financial support from NSF

Chemists design polymer-coated nanorods for drug manufacturers

House bill would strengthen federal comparative effectiveness programs

Tel Aviv University researcher devises mathematical formula for protecting the genetic privacy

ChromoCure releases development plan for CS300 Chromosomal Scanner

Globe and Mail examines HIV/AIDS rate in India

HearAtLast's Hearing Store Clinics offer "The QSound EarBud" across Canada

New technique developed for the treatment of cancer

Managing costs for clinical trials is a big challenge

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News